From the period 2022 to 2028, the Global Microfluidics Market is expected to reach USD 45.15 Billion in terms of revenue, growing at a Compound Annual Growth Rate (CAGR) of 15.90%.
The industry is being propelled forward by an increase in the number of clinical trials for cell-based therapeutics. Rapid demand for low-volume sample analysis, high-throughput screening approaches, In Vitro Diagnostics (IVD), and the development of innovative lab-on-a-chip technologies are all driving market expansion. Microfluidics Market also provides a high return on investment and aids in cost control by reducing errors. Various industry companies introduced point-of-care diagnostics, which resulted in fewer hospital visits and earlier disease detection. Industry players can now differentiate their products with less intrusive features, speed, and precision, thanks to improved technologies. As a result, Microfluidics Market has earned a name for itself in the IVD industry.
Key Highlights from the Report
- The market is segmented into Microfluidics Market-based devices and Microfluidics Market Components based on product type. The gadgets section is predicted to grow at the fastest rate over the projection period. Microfluidics Market devices have a significant potential for synthesizing nanoparticles and nanocomposites due to efficient heat and mass transfers and spatial restrictions in Microfluidics Market devices, as well as convenient parameter modifications and in situ process monitoring in microreactors. In biomedical applications like single-cell entrapment and automated micro-robotic injection, as well as drug discovery and analysis, Microfluidics Market devices are used.
- Hospitals & Diagnostic Centers, Academic & Research Institutes, and Pharmaceutical & Biotechnology Companies are the three end-user segments in the market. Microfluidics Market technologies are most commonly used in hospitals and diagnostic institutes. With the expanding financing effort in life sciences, the usage of Microfluidics Market R&D is likely to increase. Growing emphasis on releasing high-quality drugs to serve the pharmaceutical and biotechnology markets, resulting in an increase in the end-user segment.
- Asia Pacific is the fastest regional segment. In terms of growth, the Asia Pacific is a key growth market. Due to increased government support for modern infrastructure and strong intellectual property rights ownership, the market for medical diagnostics, high throughput screening, and biosensing is rising in China. Another driving element is the growing demand for healthcare services, which has boosted the demand for medical diagnostics. China, as a growing country, has enormous market potential. Due to increased R&D spending, the Microfluidics Market in the Asia Pacific is expected to grow at the quickest rate in the next years. Furthermore, the market’s expansion is fueled by the existence of key players.
Some of the key players in the Global Microfluidics Market include [object Object] and others.
Market Dynamics:
Rising demand for point-of-care testing
In the following years, the global market for point-of-care diagnostics is predicted to increase at a healthy rate of 10%. The expanding prevalence of lifestyle-related and infectious diseases, as well as the growing preference for home healthcare, are driving this growth. In addition, rising private investment and venture capital funding for the development of new products, as well as government support for enhancing PoC device usage, are boosting the PoC diagnostics industry. The increased incidence and prevalence of various diseases, as well as product downsizing and healthcare de-centralization, are likely to provide considerable potential possibilities for participants in the PoC diagnostics market.
The emergence of Microfluidics Market-based 3D cell culture systems
Organ-on-a-chip systems can be used to investigate a variety of biomedical phenomena, including medication discovery, toxicity testing, and customized therapy (where stems cells derived from individual patients can be used to identify which therapies are likely to succeed). Microfluidics Market in 3D cell culture has recently enabled the development of microenvironments that facilitate tissue differentiation and reproduce the tissue-tissue interface, spatiotemporal chemical gradients, and mechanical microenvironments of live organs.
North America dominated the market, accounting for 42.70% of the total revenue. Research institutes are playing an increasingly important role in the creation of new Microfluidics Market devices, ensuring regional dominance in the global market. Throughout the research period, the United States emerged as a crucial contributor to the region’s dominance. In addition to well-established firms, the country is home to a number of new Microfluidics Market companies.
About Vantage Market Research:
We, at Vantage Market Research, provide
quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map
out constellation of opportunities for their businesses. We, as a competitive intelligence market research
and consulting firm provide end to end solutions to our client enterprises to meet their crucial business
objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high
quality data and market research services. The company serves various enterprises and clients in a wide
variety of industries. The company offers detailed reports on multiple industries including Chemical
Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of
Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and
techniques to gather and analyse information.
Interactive Market Intelligence
Proprietary data visualization for stakeholders
Market Share Distribution
Revenue Growth (USD Bn)
